Analyst firms · Jefferies · EHAB
Jefferies EHAB price target and rating history
Enhabit Inc. (EHAB) · Health Care
Jefferies rates Enhabit Inc. (EHAB) Buy with a $9.50 price target, as of its latest action on Dec 9, 2024. It has published 3 rating actions on EHAB since August 2022, including 1 upgrade and 1 downgrade. Across 4 firms with a EHAB price target in the last 12 months, the median target is $12.90.
- Current rating
- Buy
- Price target
- $9.50
- Median target, all firms
- $12.90
- Actions on EHAB
- 3
Jefferies price target on EHAB
Every Jefferies rating on EHAB
- Dec 9, 2024
- May 9, 2024
- Aug 30, 2022
How other firms rate EHAB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Hold | $13.80 | Mar 6, 2026 |
| Oppenheimer | Outperform | $14 | Jan 22, 2026 |
| UBS | Buy | $12 | Jan 8, 2026 |
| Truist Securities | Hold | $10.50 | Jan 7, 2026 |
Questions about Jefferies and EHAB
- What is Jefferies's price target for EHAB?
- Jefferies's latest stated price target for Enhabit Inc. (EHAB) is $9.50, from its action on Dec 9, 2024.
- What is Jefferies's rating on EHAB?
- Jefferies rates EHAB Buy, a bullish rating, as of Dec 9, 2024.
- When did Jefferies last change its view on EHAB?
- On Dec 9, 2024, Jefferies upgrades to Buy from Hold, price target $8.25 to $9.50.
- How does Jefferies's EHAB target compare with other analysts?
- Across 4 firms with a EHAB price target in the last 12 months, the median target is $12.90.
More EHAB rating histories
All Jefferies ratingsEHAB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.